Patents by Inventor Carine Giovannangeli

Carine Giovannangeli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel tyrosinase-specific anti-gene oligonucleotides as depigmenting agents
    Publication number: 20100047192
    Abstract: The present invention relates to an anti-gene oligonucleotide which hybridizes specifically with the gene encoding human tyrosinase by Hoogsteen pairing between the complementary bases, said oligonucleotide forming a triple helix structure with the human tyrosinase gene. The invention also relates to the use of said oligonucleotide as a skin-depigmenting or skin-bleaching agent in a cosmetic composition or in a dermatological composition.
    Type: Application
    Filed: September 1, 2006
    Publication date: February 25, 2010
    Applicants: L.V.M.H. RECHERCHE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), MUSEUM NATIONAL D'HISTOIRE NATURELLE
    Inventors: Robin Kurfürst, Mathilde Bonnet-Duquennoy, Kristell Lazou, Carine Giovannangeli
  • Gene expression control
    Patent number: 6133024
    Abstract: The present invention relates to new vectors, pharmaceutical compositions containing them, and their therapeutical uses. More particularly, it relates to new molecules capable of acting, in a very selective and efficacious way, on the expression of genes.
    Type: Grant
    Filed: May 7, 1998
    Date of Patent: October 17, 2000
    Assignee: Aventis Pharma S.A.
    Inventors: Claude Helene, Carine Giovannangeli